Top 30 adverse event of Aducanumab at the preferred terms level.

Figshare2025-07-14 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Top_30_adverse_event_of_Aducanumab_at_the_preferred_terms_level_/29562738 数据链接链接失效反馈

官方服务：

资源简介：

Top 30 adverse event of Aducanumab at the preferred terms level.

创建时间：

2025-07-14

Treatment outcomes and adverse drug reactions during 3 months of weekly rifapentine and isoniazid for tuberculosis preventive treatment (N = 26).

结核病预防

药物不良反应监测

Treatment outcomes and adverse drug reactions during 3 months of weekly rifapentine and isoniazid for tuberculosis preventive treatment (N = 26).

NIAID Data Ecosystem30

СИНДРОМ СТИВЕНСА ДЖОНСОНА И ТОКСИЧЕСКИЙ ЭПИДЕРМАЛЬНЫЙ НЕКРОЛИЗ (СИНДРОМ ЛАЙЕЛЛА) ТЯЖЕЛЕЙШИЕ БУЛЛЕЗНЫЕ ДЕРМАТОЗЫ.

药物不良反应监测

重症皮肤黏膜病

Статья посвящена синдрому Стивенса Джонсона (ССД) и токсическому эпидермальному некролизу (ТЭН, синдром Лайелла) — тяжелым, жизнеугрожающим острым реакциям гиперчувствительности, затрагивающим кожу и

Zenodo2026-04-15 更新20

Clinical gains for residents: Comparison of first with final ADRe-p profiles (n = 19).

药物不良反应监测

临床疗效评估

Clinical gains for residents: Comparison of first with final ADRe-p profiles (n = 19).

NIAID Data Ecosystem10

Risk of low-energy hip fracture in adherent users of statins compared with adherent users of antihypertensive drugs and with randomly selected population cohort.

药物安全性评估

髋部骨折风险

*8 persons missing data on region of residence excluded. HR = Hazard ratio. †Age, coronary heart disease, rheumatoid arthritis, use of anti-diabetics, and hormone replacement therapy at cohort entry i

NIAID Data Ecosystem20

Treatment-emergent adverse events occurring during the Phase I study in at least two different subjects following a single dose of HspB5.

药物安全性评估

I期临床试验

Treatment-emergent adverse events occurring during the Phase I study in at least two different subjects following a single dose of HspB5.

NIAID Data Ecosystem10